sur Quantum Genomics (EPA:ALQGC)
Quantum Genomics files for liquidation
Quantum Genomics has filed for liquidation proceedings before the Paris Economic Court. The company has been unable to find a partner to continue its operations. Ongoing discussions have been unsuccessful, especially since its share listing on Euronext Growth has been suspended since October 25, 2024.
In the absence of new funds to cover its financial needs, Quantum Genomics declared its cessation of payments on July 3, 2025. The hearing scheduled for the Court will be held on September 2, 2025.
Shareholders will not recover their investment. Trading in the shares will remain suspended. Euronext Paris is expected to delist the shares.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Quantum Genomics